NCT06436781

Effect of Maolactin™ FMR on Exercise Recovery, Inflammation, and Muscle Comfort in an Otherwise Healthy Population

Effect of Maolactin™ FMR Supplementation on Exercise Recovery, Inflammation, and Muscle Comfort in an Otherwise Healthy Population: A Double-blind Randomized Placebo-controlled Study

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 33 (actual)
• Sponsor: RDC Clinical Pty Ltd · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This is a double blind, randomised, placebo-controlled, parallel-group trial to evaluate the effect of Maolactin FMR supplementation on post exercise inflammation, exercise recovery and muscle fatigue and pain in an otherwise healthy population of adults 18-65 years old over 10 weeks with 8 weeks of supplementation. This is PART A of the study.

Conditions

• Post Exercise Inflammation
• Exercise Recovery
• Muscle Fatigue
• Muscle Pain

Interventions

Type	Name	Description
DRUG	Maolactin	Once daily dose of 2 capsules containing a total of 500mg/day Maolactin
DRUG	Maltodextrin	Once daily dose of 2 capsules of Maltodextrin containing a total of 0mg/day Maolactin

Timeline

• Start date: 2024-09-12
• Primary completion: 2025-05-23
• Completion: 2025-05-23
• First posted: 2024-05-31
• Last updated: 2025-06-25

Locations

1 site across 1 country: Australia